{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:58:08Z","timestamp":1769849888613,"version":"3.49.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572560"],"award-info":[{"award-number":["81572560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072866"],"award-info":[{"award-number":["82072866"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bbcan.2021.188660","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T06:40:02Z","timestamp":1637131202000},"page":"188660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Liquid biopsy for ovarian cancer using circulating tumor cells: Recent advances on the path to precision medicine"],"prefix":"10.1016","volume":"1877","author":[{"given":"Jiani","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0005","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bbcan.2021.188660_bb0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amepre.2015.09.023","article-title":"A systematic review of symptoms for the diagnosis of ovarian cancer","volume":"50","author":"Ebell","year":"2016","journal-title":"Am. J. Prev. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2021.188660_bb0015","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0020","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"issue":"7353","key":"10.1016\/j.bbcan.2021.188660_bb0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nbt.2897","article-title":"Tumor signatures in the blood","volume":"32","author":"Speicher","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbcan.2017.12.005","article-title":"Circulating tumor cell-derived organoids: current challenges and promises in medical research and precision medicine","volume":"1869","author":"Praharaj","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0040","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.celrep.2017.03.025","article-title":"The mutational landscape of circulating tumor cells in multiple myeloma","volume":"19","author":"Mishima","year":"2017","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","article-title":"Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy","volume":"6","author":"Alix-Panabieres","year":"2016","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0055","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"14","key":"10.1016\/j.bbcan.2021.188660_bb0065","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1158\/0008-5472.CAN-05-0616","article-title":"Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?","volume":"65","author":"Thompson","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2021.188660_bb0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.bbcan.2021.188660_bb0075","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41419-020-02906-y","article-title":"Melatonin suppresses chronic restraint stress-mediated metastasis of epithelial ovarian cancer via NE\/AKT\/beta-catenin\/SLUG axis","volume":"11","author":"Bu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0080","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1038\/s41598-021-86122-4","article-title":"Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial-mesenchymal transition","volume":"11","author":"Yang","year":"2021","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.bbcan.2021.188660_bb0085","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1158\/0008-5472.CAN-17-2459","article-title":"Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma","volume":"78","author":"Qi","year":"2018","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2021.188660_bb0090","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ccr.2013.09.007","article-title":"Origins of metastatic traits","volume":"24","author":"Vanharanta","year":"2013","journal-title":"Cancer Cell."},{"issue":"6980","key":"10.1016\/j.bbcan.2021.188660_bb0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbcan.2021.188660_bb0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrc2622","article-title":"Metastasis: from dissemination to organ-specific colonization","volume":"9","author":"Nguyen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2021.188660_bb0105","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1339854","article-title":"Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation","volume":"6","author":"Vyas","year":"2017","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.bbcan.2021.188660_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-020-1141-9","article-title":"Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy","volume":"19","author":"Zhong","year":"2020","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0125","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/jcmm.14848","article-title":"IL-8 promotes cell migration through regulating EMT by activating the Wnt\/beta-catenin pathway in ovarian cancer","volume":"24","author":"Wen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2021.188660_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2017.01.023","article-title":"Future of circulating tumor cells in the melanoma clinical and research laboratory settings","volume":"392","author":"De Souza","year":"2017","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.devcel.2018.02.015","article-title":"Hemodynamic forces tune the arrest, adhesion, and extravasation of circulating tumor cells","volume":"45","author":"Follain","year":"2018","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2006.12.014","article-title":"Circulating tumor cells (CTC) detection: clinical impact and future directions","volume":"253","author":"Paterlini-Brechot","year":"2007","journal-title":"Cancer Lett."},{"issue":"7003","key":"10.1016\/j.bbcan.2021.188660_bb0145","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/nature02765","article-title":"Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB","volume":"430","author":"Douma","year":"2004","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0150","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41416-020-0900-0","article-title":"Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the ovarian tumour tissue analysis consortium","volume":"123","author":"Martins","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2021.188660_bb0155","doi-asserted-by":"crossref","first-page":"E854","DOI":"10.1073\/pnas.1508541113","article-title":"Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters","volume":"113","author":"Cheung","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0160","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1200\/JCO.2010.33.3716","article-title":"Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer","volume":"30","author":"Hou","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2021.188660_bb0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cell.2018.11.046","article-title":"Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding","volume":"176","author":"Gkountela","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0170","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2013.08.006","article-title":"Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients","volume":"131","author":"Liu","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2021.188660_bb0175","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1373\/clinchem.2014.224808","article-title":"ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance","volume":"60","author":"Kuhlmann","year":"2014","journal-title":"Clin. Chem."},{"issue":"16","key":"10.1016\/j.bbcan.2021.188660_bb0180","doi-asserted-by":"crossref","first-page":"14055","DOI":"10.1021\/acsami.8b02583","article-title":"Folic acid targeting for efficient isolation and detection of ovarian cancer CTCs from human whole blood based on two-step binding strategy","volume":"10","author":"Nie","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.bbcan.2021.188660_bb0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/cncr.10250","article-title":"Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis","volume":"94","author":"Marth","year":"2002","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0190","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00262-020-02750-1","article-title":"Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy","volume":"70","author":"Zaborowski","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"issue":"11","key":"10.1016\/j.bbcan.2021.188660_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112613","article-title":"The long-term prognostic significance of circulating tumor cells in ovarian cancer-a study of the OVCAD consortium","volume":"13","author":"Obermayr","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2012.09.021","article-title":"Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance \u2013 a study of the OVCAD consortium","volume":"128","author":"Obermayr","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0205","first-page":"973","article-title":"Molecular characterization of circulating tumor cells in ovarian cancer","volume":"6","author":"Kolostova","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188660_bb0210","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/1471-2407-10-666","article-title":"Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients","volume":"10","author":"Obermayr","year":"2010","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2021.188660_bb0215","first-page":"2275","article-title":"Screening for circulating tumour cells allows early detection of cancer and monitoring of treatment effectiveness: an observational study","volume":"18","author":"Ried","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"20","key":"10.1016\/j.bbcan.2021.188660_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015354","article-title":"Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer: a prospective observational study","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.bbcan.2021.188660_bb0225","first-page":"9599","article-title":"Detection of circulating tumour cells in patients with epithelial ovarian cancer by a microfluidic system","volume":"10","author":"Rao","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0230","doi-asserted-by":"crossref","first-page":"812","DOI":"10.18632\/oncotarget.22549","article-title":"Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells","volume":"9","author":"Obermayr","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0235","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2017.02.042","article-title":"Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer","volume":"145","author":"Lee","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0240","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","article-title":"Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer","volume":"112","author":"Fan","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0245","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/s41467-018-05793-2","article-title":"The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner","volume":"9","author":"Agerbaek","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2021.188660_bb0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2019.10.014","article-title":"Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: ready for prime time?","volume":"468","author":"Asante","year":"2020","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.bbcan.2021.188660_bb0255","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1039\/C6CS00803H","article-title":"Current detection technologies for circulating tumor cells","volume":"46","author":"Shen","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bbcan.2021.188660_bb0260","first-page":"2247","article-title":"One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles","volume":"8","author":"Kim","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.bbcan.2021.188660_bb0265","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10549-008-0290-0","article-title":"Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR","volume":"118","author":"Sieuwerts","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0270","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/IGC.0b013e318216cb91","article-title":"Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy","volume":"21","author":"Aktas","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2015.03.002","article-title":"Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs)","volume":"137","author":"Pearl","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188660_bb0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cca.2014.02.019","article-title":"Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization","volume":"433","author":"Ning","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.bbcan.2021.188660_bb0285","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.molonc.2016.04.002","article-title":"Gene expression profiling of single circulating tumor cells in ovarian cancer - establishment of a multi-marker gene panel","volume":"10","author":"Blassl","year":"2016","journal-title":"Mol. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2021.188660_bb0290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10555-012-9398-0","article-title":"Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials","volume":"32","author":"Bidard","year":"2013","journal-title":"Cancer Metastasis Rev."},{"issue":"43","key":"10.1016\/j.bbcan.2021.188660_bb0295","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1039\/C9TB01490J","article-title":"Advanced liquid biopsy technologies for circulating biomarker detection","volume":"7","author":"Soda","year":"2019","journal-title":"J. Mater. Chem. B"},{"issue":"4","key":"10.1016\/j.bbcan.2021.188660_bb0300","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.biotechadv.2018.05.002","article-title":"Circulating tumor microemboli: progress in molecular understanding and enrichment technologies","volume":"36","author":"Umer","year":"2018","journal-title":"Biotechnol. Adv."},{"issue":"22","key":"10.1016\/j.bbcan.2021.188660_bb0305","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1158\/0008-5472.CAN-20-1216","article-title":"Morphology-predicted large-scale transition number in circulating tumor cells identifies a chromosomal instability biomarker associated with poor outcome in castration-resistant prostate cancer","volume":"80","author":"Schonhoft","year":"2020","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2021.188660_bb0310","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/cyto.a.23568","article-title":"Automated rare single cell picking with the ALS cellcelector","volume":"93","author":"Nelep","year":"2018","journal-title":"Cytometry A"},{"issue":"24","key":"10.1016\/j.bbcan.2021.188660_bb0315","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1039\/C9CS00174C","article-title":"Superparamagnetic nanoarchitectures for disease-specific biomarker detection","volume":"48","author":"Masud","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"10.1016\/j.bbcan.2021.188660_bb0320","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1021\/ja500169y","article-title":"Robust nonenzymatic hybrid nanoelectrocatalysts for signal amplification toward ultrasensitive electrochemical cytosensing","volume":"136","author":"Zheng","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0325","article-title":"An automatic platform based on nanostructured microfluidic chip for isolating and identification of circulating tumor cells","volume":"12","author":"Jou","year":"2021","journal-title":"Micromachines (Basel)"},{"issue":"20","key":"10.1016\/j.bbcan.2021.188660_bb0330","article-title":"Reversible immunoaffinity interface enables dynamic manipulation of trapping force for accumulated capture and efficient release of circulating rare cells","volume":"8","author":"Chen","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bbcan.2021.188660_bb0335","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012419-032611","article-title":"Human organoids: tools for understanding biology and treating diseases","volume":"15","author":"Schutgens","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"10.1016\/j.bbcan.2021.188660_bb0340","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35043102","article-title":"Human cancer cell lines: fact and fantasy","volume":"1","author":"Masters","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2021.188660_bb0345","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.celrep.2018.10.096","article-title":"Integrated genomic, epigenomic, and expression analyses of ovarian cancer cell lines","volume":"25","author":"Papp","year":"2018","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.bbcan.2021.188660_bb0350","first-page":"1203","article-title":"Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers","volume":"7","author":"Kolostova","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"6193","key":"10.1016\/j.bbcan.2021.188660_bb0355","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1126\/science.1253533","article-title":"Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility","volume":"345","author":"Yu","year":"2014","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050505","article-title":"Current status of patient-derived ovarian cancer models","volume":"8","author":"Maru","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.bbcan.2021.188660_bb0365","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nbt.2576","article-title":"Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay","volume":"31","author":"Baccelli","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0370","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41467-020-15426-2","article-title":"Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model","volume":"11","author":"Faugeroux","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bbcan.2021.188660_bb0375","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/ijc.32001","article-title":"CTCs-derived xenograft development in a triple negative breast cancer case","volume":"144","author":"Pereira-Veiga","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"7244","key":"10.1016\/j.bbcan.2021.188660_bb0380","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010019","article-title":"Circulating tumor cell-derived pre-clinical models for personalized medicine","volume":"11","author":"Tellez-Gabriel","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.bbcan.2021.188660_bb0390","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ygyno.2020.03.026","article-title":"Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma","volume":"157","author":"Chen","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2021.188660_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107762","article-title":"Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter- and intrapatient drug responses","volume":"31","author":"de Witte","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2021.188660_bb0400","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/OTT.S288191","article-title":"Combined serum DKK3 and circulating CD133 cells as prognostic biomarkers for ovarian cancer patients","volume":"14","author":"Nie","year":"2021","journal-title":"Onco Targets Ther."},{"issue":"4","key":"10.1016\/j.bbcan.2021.188660_bb0405","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00404-020-05477-7","article-title":"Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer","volume":"301","author":"Banys-Paluchowski","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"issue":"3","key":"10.1016\/j.bbcan.2021.188660_bb0410","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2014.06.013","article-title":"Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer","volume":"134","author":"Pearl","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2021.188660_bb0415","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","article-title":"Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer","volume":"122","author":"Poveda","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2011.06.022","article-title":"Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a gynecologic oncology group study","volume":"123","author":"Behbakht","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0425","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2003.08.004","article-title":"Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer","volume":"91","author":"Judson","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188660_bb0430","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2147\/OTT.S307546","article-title":"Artificial intelligence based on blood biomarkers including CTCs predicts outcomes in epithelial ovarian cancer: a prospective study","volume":"14","author":"Ma","year":"2021","journal-title":"Onco Targets Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0435","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ygyno.2021.02.024","article-title":"Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: a meta-analysis","volume":"161","author":"Huang","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188660_bb0440","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3389\/fonc.2019.01015","article-title":"Soluble programmed death receptor ligands sPD-L1 and sPD-L2 as liquid biopsy markers for prognosis and platinum response in epithelial ovarian cancer","volume":"9","author":"Buderath","year":"2019","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2021.188660_bb0445","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/1541-7786.MCR-11-0021","article-title":"Targeting cell spreading: a method of sensitizing metastatic tumor cells to TRAIL-induced apoptosis","volume":"9","author":"Phipps","year":"2011","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2021.188660_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051218","article-title":"Circulating tumor cells characterization revealed TIMP1 as a potential therapeutic target in ovarian cancer","volume":"9","author":"Abreu","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0455","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13045-018-0658-5","article-title":"Selective killing of circulating tumor cells prevents metastasis and extends survival","volume":"11","author":"Kim","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188660_bb0460","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/0008-5472.CAN-20-1674","article-title":"Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high-grade serous ovarian cancer","volume":"81","author":"Wan","year":"2021","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2021.188660_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020376","article-title":"Clinical relevance of immune checkpoints on circulating tumor cells in breast cancer","volume":"12","author":"Papadaki","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.bbcan.2021.188660_bb0470","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41568-019-0180-2","article-title":"Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells","volume":"19","author":"Keller","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"43","key":"10.1016\/j.bbcan.2021.188660_bb0475","doi-asserted-by":"crossref","first-page":"39586","DOI":"10.1021\/acsami.9b14051","article-title":"High-efficiency isolation and rapid identification of heterogeneous circulating tumor cells (CTCs) using dual-antibody-modified fluorescent-magnetic nanoparticles","volume":"11","author":"Wang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2100158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2100158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:33:52Z","timestamp":1759638832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X2100158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0304419X2100158X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2021.188660","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid biopsy for ovarian cancer using circulating tumor cells: Recent advances on the path to precision medicine","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2021.188660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"188660"}}